Pateclizumab (MLTA3698A) is a humanized antibody against lymphotoxin alpha (LTalpha), a transiently expressed cytokine on activated B and T cells (Th1, Th17), which are implicated in rheumatoid arthritis (RA) pathogenesis[1].
Molecular Weight:
(144.9 kDa)
Purity:
99
CAS Number:
[1202526-59-7]
Target:
Others
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted